Physician profile
Ryan Bailey
NPI 1487180238
$18,017.48
in general payments reported to CMS, 2019-2025
10 companies · $3,146 in 2025
The $3,146 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $1,501 · 2021: $551 · 2022: $2,778 · 2023: $6,194 · 2024: $3,472 · 2025: $3,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,332 · Food and Beverage: $4,302 · Consulting Fee: $2,100 · Education: $77.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,332.15 |
| Food and Beverage | $4,302.47 |
| Consulting Fee | $2,100.00 |
| Education | $77.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,939.88 | 2019-2025 | Mako, Accolade, Triathlon |
| Smith+Nephew, INC. | $3,661.91 | 2023-2024 | Journey II, Legion Revision, Or3o Dual Mobility |
| Elite Orthopedics, LLC | $2,358.62 | 2020-2022 | |
| Merete Technologies, INC | $2,100.00 | 2023 | |
| Zimmer Biomet Holdings, INC. | $2,026.94 | 2022-2025 | Oxford, Persona, G7 |
| Medical Device Business Services, INC. | $1,694.67 | 2019-2024 | Actis |
| Medacta USA, INC. | $936.57 | 2021-2022 | |
| Depuy Synthes Sales INC. | $229.63 | 2022-2023 | Actis, Attune |
| Integra Lifesciences Corporation | $57.31 | 2021 | |
| Axogen | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.